Arcade Beauty's Socoplan plant in the Deux-Sèvres region of France, which specializes in samples and single-dose cosmetics, has successfully passed tests to ensure compliance with American and Canadian regulations for the packaging of OTC beauty and skincare products in North America. These include sun creams, make-up products containing sun filters, serums, specific skin care or anti-acne treatments, as well as other specialties, sold in pharmacies and parapharmacies.
Arcade Beauty Socoplan can now guarantee beauty brands regulatory compliance on the North American market, following the control audit commissioned this summer by the US and Canadian health authorities.
In the USA and Canada, certain cosmetic products are classified as OTC (Over the Counter), over-the-counter medicines.
Two audits were successfully completed in the summer of 2016. This regulatory audit covered the assessment of compliance with Current Good Manufacturing Practices (FDA standard in the USA and Canadian standard) of all processes. It required the collaboration and energy of all the site's teams, who were heavily involved and mobilized in this project.
Combined with the ISO 22716 European cosmetics approval already held by the company, this new qualification enables Arcade Beauty Socoplan to provide brands with answers to their growing regulatory requirements.
